Garden Stage (NASDAQ:GSIW) Trading 3.5% Higher – Should You Buy?

Garden Stage Limited (NASDAQ:GSIWGet Free Report)’s share price was up 3.5% during trading on Thursday . The stock traded as high as $27.70 and last traded at $24.7460. Approximately 6,241 shares changed hands during trading, a decline of 32% from the average daily volume of 9,212 shares. The stock had previously closed at $23.90.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Garden Stage from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, June 8th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Garden Stage has an average rating of “Sell”.

Check Out Our Latest Report on Garden Stage

Garden Stage Price Performance

The business has a fifty day moving average of $28.74 and a 200-day moving average of $26.31.

Institutional Inflows and Outflows

An institutional investor recently raised its stake in Garden Stage stock. XTX Topco Ltd grew its holdings in shares of Garden Stage Limited (NASDAQ:GSIWFree Report) by 244.5% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 258,052 shares of the company’s stock after purchasing an additional 183,147 shares during the period. XTX Topco Ltd owned approximately 0.72% of Garden Stage worth $33,000 at the end of the most recent reporting period. Institutional investors own 0.47% of the company’s stock.

Garden Stage Company Profile

(Get Free Report)

Garden Stage Limited, through its subsidiaries, provides securities dealing and brokerage, underwriting and placing, and other financial services in Hong Kong. It also offers asset management services comprising discretionary account management and fund management services. The company was incorporated in 2022 and is headquartered in Central, Hong Kong. Garden Stage Limited operates as a subsidiary of Oriental Moon Tree Limited.

Further Reading

Receive News & Ratings for Garden Stage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Garden Stage and related companies with MarketBeat.com's FREE daily email newsletter.